<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33453999</PMID><DateCompleted><Year>2021</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>19</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>295</Volume><Issue>51</Issue><PubDate><Year>2020</Year><Month>Dec</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>Wildtype &#x3c3;1 receptor and the receptor agonist improve ALS-associated mutation-induced insolubility and toxicity.</ArticleTitle><Pagination><StartPage>17573</StartPage><EndPage>17587</EndPage><MedlinePgn>17573-17587</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1074/jbc.RA120.015012</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(17)50641-9</ELocationID><Abstract><AbstractText>Genetic mutations related to ALS, a progressive neurological disease, have been discovered in the gene encoding &#x3c3;-1 receptor (&#x3c3;1R). We previously reported that &#x3c3;1RE102Q elicits toxicity in cells. The &#x3c3;1R forms oligomeric states that are regulated by ligands. Nevertheless, little is known about the effect of ALS-related mutations on oligomer formation. Here, we transfected NSC-34 cells, a motor neuronal cell line, and HEK293T cells with &#x3c3;1R-mCherry (mCh), &#x3c3;1RE102Q-mCh, or nontagged forms to investigate detergent solubility and subcellular distribution using immunocytochemistry and fluorescence recovery after photobleaching. The oligomeric state was determined using crosslinking procedure. &#x3c3;1Rs were soluble to detergents, whereas the mutants accumulated in the insoluble fraction. Within the soluble fraction, peak distribution of mutants appeared in higher sucrose density fractions. Mutants formed intracellular aggregates that were co-stained with p62, ubiquitin, and phosphorylated pancreatic eukaryotic translation initiation factor-2-&#x3b1; kinase in NSC-34 cells but not in HEK293T cells. The aggregates had significantly lower recovery in fluorescence recovery after photobleaching. Acute treatment with &#x3c3;1R agonist SA4503 failed to improve recovery, whereas prolonged treatment for 48 h significantly decreased &#x3c3;1RE102Q-mCh insolubility and inhibited apoptosis. Whereas &#x3c3;1R-mCh formed monomers and dimers, &#x3c3;1RE102Q-mCh also formed trimers and tetramers. SA4503 reduced accumulation of the four types in the insoluble fraction and increased monomers in the soluble fraction. The &#x3c3;1RE102Q insolubility was diminished by &#x3c3;1R-mCh co-expression. These results suggest that the agonist and WT &#x3c3;1R modify the detergent insolubility, toxicity, and oligomeric state of &#x3c3;1RE102Q, which may lead to promising new treatments for &#x3c3;1R-related ALS.</AbstractText><CopyrightInformation>Copyright &#xa9; 2020 &#xa9; 2020 Shinoda et al. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shinoda</LastName><ForeName>Yasuharu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haga</LastName><ForeName>Yudai</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akagawa</LastName><ForeName>Koichiro</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fukunaga</LastName><ForeName>Kohji</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Japan. Electronic address: koji.fukunaga.c1@tohoku.ac.jp.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008164">Luminescent Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010879">Piperazines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D066329">Protein Aggregates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017480">Receptors, sigma</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011993">Recombinant Fusion Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C413662">red fluorescent protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C106106">sigma-1 receptor</NameOfSubstance></Chemical><Chemical><RegistryNumber>9J7A4144BX</RegistryNumber><NameOfSubstance UI="C101789">SA 4503</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D059865" MajorTopicYN="N">Endoplasmic Reticulum Stress</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036681" MajorTopicYN="N">Fluorescence Recovery After Photobleaching</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008164" MajorTopicYN="N">Luminescent Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016297" MajorTopicYN="N">Mutagenesis, Site-Directed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066329" MajorTopicYN="N">Protein Aggregates</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055503" MajorTopicYN="N">Protein Multimerization</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017480" MajorTopicYN="N">Receptors, sigma</DescriptorName><QualifierName UI="Q000819" MajorTopicYN="N">agonists</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011993" MajorTopicYN="N">Recombinant Fusion Proteins</DescriptorName><QualifierName UI="Q000096" MajorTopicYN="N">biosynthesis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012995" MajorTopicYN="N">Solubility</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis (ALS) (Lou Gehrig disease)</Keyword><Keyword MajorTopicYN="N">cell death</Keyword><Keyword MajorTopicYN="N">fluorescence recovery after photobleaching (FRAP)</Keyword><Keyword MajorTopicYN="N">oligomerization</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">subcellular fractionation</Keyword><Keyword MajorTopicYN="N">&#x3c3; receptor</Keyword></KeywordList><CoiStatement><i>Conflict of interest</i>&#x2014;The authors declare that they have no conflicts of interest with the contents of this article. The authors declare that they have no conflicts of interest with the contents of this article</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>1</Month><Day>17</Day><Hour>20</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>1</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33453999</ArticleId><ArticleId IdType="pmc">PMC7762949</ArticleId><ArticleId IdType="doi">10.1074/jbc.RA120.015012</ArticleId><ArticleId IdType="pii">S0021-9258(17)50641-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Martin W. R., Eades C. G., Thompson J. A., Huppler R. E., and Gilbert P. E. (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J. Pharmacol. Exp. Ther. 197, 517&#x2013;532</Citation><ArticleIdList><ArticleId IdType="pubmed">945347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam S. W., and Cook L. (1984) &#x3c3; opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF 10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc. Natl. Acad. Sci. U. S. A. 81, 5618&#x2013;5621 10.1073/pnas.81.17.5618</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.81.17.5618</ArticleId><ArticleId IdType="pmc">PMC391758</ArticleId><ArticleId IdType="pubmed">6147851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mickelson M. M., and Lahti R. A. (1985) Demonstration of non-opioid sigma binding with (d)3H-SKF 10047 in guinea pig brain. Res. Commun. Chem. Pathol. Pharmacol. 47, 255&#x2013;263</Citation><ArticleIdList><ArticleId IdType="pubmed">2986252</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H. R., Zheng S., Gurpinar E., Koehl A., Manglik A., and Kruse A. C. (2016) Crystal structure of the human &#x3c3;1 receptor. Nature 532, 527&#x2013;530 10.1038/nature17391</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature17391</ArticleId><ArticleId IdType="pmc">PMC5550834</ArticleId><ArticleId IdType="pubmed">27042935</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavylutov T., Chen X., Guo L., and Yang J. (2018) APEX2- tagging of &#x3c3; 1-receptor indicates subcellular protein topology with cytosolic N-terminus and ER luminal C-terminus. Protein Cell 9, 733&#x2013;737 10.1007/s13238-017-0468-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-017-0468-5</ArticleId><ArticleId IdType="pmc">PMC6053353</ArticleId><ArticleId IdType="pubmed">28929457</ArticleId></ArticleIdList></Reference><Reference><Citation>Su T. P., Su T. C., Nakamura Y., and Tsai S. Y. (2016) The &#x3c3;1 receptor as a pluripotent modulator in living systems. Trends Pharmacol. Sci. 37, 262&#x2013;278 10.1016/j.tips.2016.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2016.01.003</ArticleId><ArticleId IdType="pmc">PMC4811735</ArticleId><ArticleId IdType="pubmed">26869505</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt H. R., and Kruse A. C. (2019) The molecular function of &#x3c3; receptors: past, present, and future. Trends Pharmacol. Sci. 40, 636&#x2013;654 10.1016/j.tips.2019.07.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2019.07.006</ArticleId><ArticleId IdType="pmc">PMC6748033</ArticleId><ArticleId IdType="pubmed">31387763</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontanilla D., Johannessen M., Hajipour A. R., Cozzi N. V., Jackson M. B., and Ruoho A. E. (2009) The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous &#x3c3;1 receptor regulator. Science. 323, 934&#x2013;937 10.1126/science.1166127</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1166127</ArticleId><ArticleId IdType="pmc">PMC2947205</ArticleId><ArticleId IdType="pubmed">19213917</ArticleId></ArticleIdList></Reference><Reference><Citation>Su T. P., Hayashi T., Maurice T., Buch S., and Ruoho A. E. (2010) The &#x3c3;1 receptor chaperone as an inter-organelle signaling modulator. Trends Pharmacol. Sci. 31, 557&#x2013;566 10.1016/j.tips.2010.08.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2010.08.007</ArticleId><ArticleId IdType="pmc">PMC2993063</ArticleId><ArticleId IdType="pubmed">20869780</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhuiyan M. S., Tagashira H., and Fukunaga K. (2011) &#x3c3;1 receptor stimulation with fluvoxamine activates Akt-eNOS signaling in the thoracic aorta of ovariectomized rats with abdominal aortic banding. Eur. J. Pharmacol. 650, 621&#x2013;628 10.1016/j.ejphar.2010.10.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2010.10.055</ArticleId><ArticleId IdType="pubmed">21044620</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan N. K., Visser A. K. D., Schepers M., Luurtsema G., Nyakas C. J., Elsinga P. H., Ishiwata K., Dierckx R. A. J. O., and Van Waarde A. (2014) Dose-dependent &#x3c3;1 receptor occupancy by donepezil in rat brain can be assessed with 11C-SA4503 and microPET. Psychopharmacology (Berl) 231, 3997&#x2013;4006 10.1007/s00213-014-3533-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-014-3533-2</ArticleId><ArticleId IdType="pubmed">24639047</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Saif A., Al-Mohanna F., and Bohlega S. (2011) A mutation in &#x3c3;1 receptor causes juvenile amyotrophic lateral sclerosis. Ann. Neurol. 70, 913&#x2013;919 10.1002/ana.22534</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22534</ArticleId><ArticleId IdType="pubmed">21842496</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X., Hu Z., Liu L., Xie Y., Zhan Y., Zi X., Wang J., Wu L., Xia K., Tang B., and Zhang R. (2015) A SIGMAR1 splice-site mutation causes distal hereditary motor neuropathy. Neurology. 84, 2430&#x2013;2437 10.1212/WNL.0000000000001680</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001680</ArticleId><ArticleId IdType="pubmed">26078401</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregianin E., Pallafacchina G., Zanin S., Crippa V., Rusmini P., Poletti A., Fang M., Li Z., Diano L., Petrucci A., Lispi L., Cavallaro T., Fabrizi G. M., Muglia M., Boaretto F., et al. (2016) Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling. Hum. Mol. Genet. 25, 3741&#x2013;3753 10.1093/hmg/ddw220</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddw220</ArticleId><ArticleId IdType="pubmed">27402882</ArticleId></ArticleIdList></Reference><Reference><Citation>Horga A., Tomaselli P. J., Gonzalez M. A., Laur&#xe0; M., Muntoni F., Manzur A. Y., Hanna M. G., Blake J. C., Houlden H., Z&#xfc;chner S., and Reilly M. M. (2016) SIGMAR1 mutation associated with autosomal recessive Silver-like syndrome. Neurology. 87, 1607&#x2013;1612 10.1212/WNL.0000000000003212</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000003212</ArticleId><ArticleId IdType="pmc">PMC5067545</ArticleId><ArticleId IdType="pubmed">27629094</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe S., Ilieva H., Tamada H., Nomura H., Komine O., Endo F., Jin S., Mancias P., Kiyama H., and Yamanaka K. (2016) Mitochondria-associated membrane collapse is a common pathomechanism in SIGMAR1- and SOD1-linked ALS. EMBO Mol. Med. 8, 1421&#x2013;1437 10.15252/emmm.201606403</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201606403</ArticleId><ArticleId IdType="pmc">PMC5167132</ArticleId><ArticleId IdType="pubmed">27821430</ArticleId></ArticleIdList></Reference><Reference><Citation>Almendra L., Laranjeira F., Fern&#xe1;ndez-Marmiesse A., and Negr&#xe3;o L. (2018) SIGMAR1 gene mutation causing distal hereditary motor neuropathy in a Portuguese family. Acta Myol. 37, 2&#x2013;4</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6060428</ArticleId><ArticleId IdType="pubmed">30079398</ArticleId></ArticleIdList></Reference><Reference><Citation>Izumi Y., Morino H., Miyamoto R., Matsuda Y., Ohsawa R., Kurashige T., Shimatani Y., Kaji R., and Kawakami H. (2018) Compound heterozygote mutations in the SIGMAR1 gene in an oldest-old patient with amyotrophic lateral sclerosis. Geriatr. Gerontol. Int. 18, 1519&#x2013;1520 10.1111/ggi.13506</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ggi.13506</ArticleId><ArticleId IdType="pubmed">30311446</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandhagopal R., Meftah D., Al-Kalbani S., and Scott P. (2018) Recessive distal motor neuropathy with pyramidal signs in an Omani kindred: underlying novel mutation in the SIGMAR1 gene. Eur. J. Neurol. 25, 395&#x2013;403 10.1111/ene.13519</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13519</ArticleId><ArticleId IdType="pubmed">29115704</ArticleId></ArticleIdList></Reference><Reference><Citation>Ververis A., Dajani R., Koutsou P., Aloqaily A., Nelson-Williams C., Loring E., Arafat A., Mubaidin A. F., Horany K., Bader M. B., Al-Baho Y., Ali B., Muhtaseb A., Despenza T., Al-Qudah A. A., et al. (2020) Distal hereditary motor neuronopathy of the Jerash type is caused by a novel SIGMAR1 c.500A&gt;T missense mutation. J. Med. Genet. 57, 178&#x2013;186 10.1136/jmedgenet-2019-106108</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmedgenet-2019-106108</ArticleId><ArticleId IdType="pmc">PMC7042970</ArticleId><ArticleId IdType="pubmed">31511340</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H., Shinoda Y., Shioda N., and Fukunaga K. (2014) Methyl pyruvate rescues mitochondrial damage caused by SIGMAR1 mutation related to amyotrophic lateral sclerosis. Biochim. Biophys. Acta 1840, 3320&#x2013;3334 10.1016/j.bbagen.2014.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2014.08.012</ArticleId><ArticleId IdType="pubmed">25175561</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J. P., Hardy J., and Fischbeck K. H. (2002) Toxic proteins in neurodegenerative disease. Science 296, 1991&#x2013;1995 10.1126/science.1067122</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1067122</ArticleId><ArticleId IdType="pubmed">12065827</ArticleId></ArticleIdList></Reference><Reference><Citation>Blokhuis A. M., Groen E. J. N., Koppers M., Van Den Berg L. H., and Pasterkamp R. J. (2013) Protein aggregation in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 777&#x2013;794 10.1007/s00401-013-1125-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1125-6</ArticleId><ArticleId IdType="pmc">PMC3661910</ArticleId><ArticleId IdType="pubmed">23673820</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H. X., Chen W., Hong S. T., Boycott K. M., Gorrie G. H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G. H., Donkervoort S., et al. (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211&#x2013;215 10.1038/nature10353</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Yan J., Vemula S. P., Liu E., Yang Y., Chen W., Zheng J. G., Shi Y., Siddique N., Arrat H., Donkervoort S., Ajroud-Driss S., Sufit R. L., Heller S. L., Deng H. X., et al. (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 68, 1440&#x2013;1446 10.1001/archneurol.2011.250</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano M., Nakamura Y., Saigoh K., Sakamoto H., Ueno S., Isono C., Miyamoto K., Akamatsu M., Mitsui Y., and Kusunoki S. (2013) Mutations in the gene encoding p62 in Japanese patients with amyotrophic lateral sclerosis. Neurology 80, 458&#x2013;463 10.1212/WNL.0b013e31827f0fe5</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827f0fe5</ArticleId><ArticleId IdType="pubmed">23303844</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Ber I., Camuzat A., Guerreiro R., Bouya-Ahmed K., Bras J., Nicolas G., Gabelle A., Didic M., De Septenville A., Millecamps S., Lenglet T., Latouche M., Kabashi E., Campion D., Hannequin D., et al. . French Clinical and Genetic Research Network on FTD/FTD-ALS, (2013) SQSTM1 mutations in French patients with frontotemporal dementia or frontotemporal dementia with amyotrophic lateral sclerosis. JAMA Neurol. 70, 1403&#x2013;1410 10.1001/jamaneurol.2013.3849</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2013.3849</ArticleId><ArticleId IdType="pmc">PMC4199096</ArticleId><ArticleId IdType="pubmed">24042580</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahed A. C., McDonough B., Gouvion C. M., Newell K. L., Dure L. S., Bebin M., Bick A. G., Seidman J. G., Harter D. H., and Seidman C. E. (2014) UBQLN2 mutation causing heterogeneous X-linked dominant neurodegeneration. Ann. Neurol. 75, 793&#x2013;798 10.1002/ana.24164</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24164</ArticleId><ArticleId IdType="pmc">PMC4106259</ArticleId><ArticleId IdType="pubmed">24771548</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., and Su T. (2003) &#x3c3;1 receptors (&#x3c3;1 binding sites) form raft-like microdomains and target lipid droplets on the endoplasmic reticulum: roles in endoplasmic reticulum lipid compartmentalization and export. J. Pharmacol. Exp. Ther. 306, 718&#x2013;725 10.1124/jpet.103.051284</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.051284</ArticleId><ArticleId IdType="pubmed">12730355</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., and Su T. P. (2007) &#x3c3;1 receptor chaperones at the ER-mitochondrion interface regulate Ca2+ signaling and cell survival. Cell 131, 596&#x2013;610 10.1016/j.cell.2007.08.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.08.036</ArticleId><ArticleId IdType="pubmed">17981125</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., and Fujimoto M. (2010) Detergent-resistant microdomains determine the localization of &#x3c3;1 receptors to the endoplasmic reticulum-mitochondria junction. Mol. Pharmacol. 77, 517&#x2013;528 10.1124/mol.109.062539</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.109.062539</ArticleId><ArticleId IdType="pmc">PMC2845942</ArticleId><ArticleId IdType="pubmed">20053954</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., and Su T. P. (2003) Intracellular dynamics of &#x3c3;1 receptors (&#x3c3;1 binding sites) in NG108-15 cells. J. Pharmacol. Exp. Ther. 306, 726&#x2013;733 10.1124/jpet.103.051292</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.103.051292</ArticleId><ArticleId IdType="pubmed">12730356</ArticleId></ArticleIdList></Reference><Reference><Citation>Gromek K. A., Suchy F. P., Meddaugh H. R., Wrobel R. L., LaPointe L. M., Chu U. B., Primm J. G., Ruoho A. E., Senes A., and Fox B. G. (2014) The oligomeric states of the purified &#x3c3;1 receptor are stabilized by ligands. J. Biol. Chem. 289, 20333&#x2013;20344 10.1074/jbc.M113.537993</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.537993</ArticleId><ArticleId IdType="pmc">PMC4106346</ArticleId><ArticleId IdType="pubmed">24847081</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-Soler M., Fern&#xe1;ndez-Due&#xf1;as V., Portillo-Salido E., P&#xe9;rez P., Zamanillo D., Vela J. M., Burgue&#xf1;o J., and Ciruela F. (2014) Predicting the antinociceptive efficacy of &#x3c3;1 receptor ligands by a novel receptor fluorescence resonance energy transfer (FRET) based biosensor. J. Med. Chem. 57, 238&#x2013;242 10.1021/jm401529t</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jm401529t</ArticleId><ArticleId IdType="pubmed">24354313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A. K., Mavlyutov T., Singh D. R., Biener G., Yang J., Oliver J. A., Ruoho A., and Raicu V. (2015) The &#x3c3;1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem. J. 466, 263&#x2013;271 10.1042/BJ20141321</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20141321</ArticleId><ArticleId IdType="pmc">PMC4500508</ArticleId><ArticleId IdType="pubmed">25510962</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu U. B., and Ruoho A. E. (2016) Biochemical pharmacology of the &#x3c3;1 receptor. Mol. Pharmacol. 89, 142&#x2013;153 10.1124/mol.115.101170</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.115.101170</ArticleId><ArticleId IdType="pubmed">26560551</ArticleId></ArticleIdList></Reference><Reference><Citation>Marriott K.-S. C., Prasad M., Thapliyal V., and Bose H. S. (2012) &#x3c3;1 receptor at the mitochondrial-associated endoplasmic reticulum membrane. J. Pharmacol. Exp. Ther. 343, 578&#x2013;586 10.1124/jpet.112.198168</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.112.198168</ArticleId><ArticleId IdType="pmc">PMC3500540</ArticleId><ArticleId IdType="pubmed">22923735</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori T., Hayashi T., Hayashi E., and Su T. P. (2013) &#x3c3;1 receptor chaperone at the ER-mitochondrion interface mediates the mitochondrion-ER-nucleus signaling for cellular survival. PLoS ONE 8, e76941 10.1371/journal.pone.0076941</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0076941</ArticleId><ArticleId IdType="pmc">PMC3799859</ArticleId><ArticleId IdType="pubmed">24204710</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., Vollrath J. T., Sechi A., Johann S., Roos A., Yamoah A., Katona I., Bohlega S., Wiemuth D., Tian Y., Schmidt A., Vervoorts J., Dohmen M., Beyer C., Anink J., et al. (2017) The ALS-linked E102Q mutation in &#x3c3; receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 24, 1655&#x2013;1671 10.1038/cdd.2017.88</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.88</ArticleId><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bosch L., Verhoeven K., De Smedt H., Wuytack F., Missiaen L., and Robberecht W. (1999) Calcium handling proteins in isolated spinal motoneurons. Life Sci. 65, 1597&#x2013;1606 10.1016/S0024-3205(99)00405-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0024-3205(99)00405-1</ArticleId><ArticleId IdType="pubmed">10574226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubota H., Kitamura A., and Nagata K. (2011) Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones. Methods 53, 267&#x2013;274 10.1016/j.ymeth.2010.12.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymeth.2010.12.035</ArticleId><ArticleId IdType="pubmed">21195182</ArticleId></ArticleIdList></Reference><Reference><Citation>Reits E. A. J., and Neefjes J. J. (2001) From fixed to FRAP: Measuring protein mobility and activity in living cells. Nat. Cell Biol. 3, E145&#x2013;E147 10.1038/35078615</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35078615</ArticleId><ArticleId IdType="pubmed">11389456</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena S., Cabuy E., and Caroni P. (2009) A role for motoneuron subtype-selective ER stress in disease manifestations of FALS mice. Nat. Neurosci. 12, 627&#x2013;636 10.1038/nn.2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2297</ArticleId><ArticleId IdType="pubmed">19330001</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerneus D. P., Ueffing E., Posthuma G., Strous G. J., and Van der Ende A. (1993) Detergent insolubility of alkaline phosphatase during biosynthetic transport and endocytosis. Role of cholesterol. J. Biol. Chem. 268, 3150&#x2013;3155</Citation><ArticleIdList><ArticleId IdType="pubmed">8428991</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanada K., Nishijima M., Akamatsu Y., and Pagano R. E. (1995) Both sphingolipids and cholesterol participate in the detergent insolubility of alkaline phosphatase, a glycosylphosphatidylinositol-anchored protein, in mammalian membranes. J. Biol. Chem. 270, 6254&#x2013;6260 10.1074/jbc.270.11.6254</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.270.11.6254</ArticleId><ArticleId IdType="pubmed">7890763</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong A. Y. C., Hristova E., Ahlskog N., Tasse L. A., Ngsee J. K., Chudalayandi P., and Bergeron R. (2016) Aberrant subcellular dynamics of &#x3c3;1 receptor mutants underlying neuromuscular diseases. Mol. Pharmacol. 90, 238&#x2013;253 10.1124/mol.116.104018</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/mol.116.104018</ArticleId><ArticleId IdType="pubmed">27418673</ArticleId></ArticleIdList></Reference><Reference><Citation>Yano H., Bonifazi A., Xu M., Guthrie D. A., Schneck S. N., Abramyan A. M., Fant A. D., Hong W. C., Newman A. H., and Shi L. (2018) Pharmacological profiling of &#x3c3; 1 receptor ligands by novel receptor homomer assays. Neuropharmacology 133, 264&#x2013;275 10.1016/j.neuropharm.2018.01.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2018.01.042</ArticleId><ArticleId IdType="pmc">PMC5858991</ArticleId><ArticleId IdType="pubmed">29407216</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang N., Li R.-H., Ma L., Li N., Shan P.-Y., Wang X.-B., and Liu A.-F. (2019) The effects of terminal tagging on homomeric interactions of the &#x3c3; 1 receptor. Front. Neurosci. 13, 1&#x2013;8 10.3389/fnins.2019.01356</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2019.01356</ArticleId><ArticleId IdType="pmc">PMC6930887</ArticleId><ArticleId IdType="pubmed">31920515</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong W. C. (2020) Distinct regulation of &#x3c3;1 receptor multimerization by its agonists and antagonists in transfected cells and rat liver membranes. J. Pharmacol. Exp. Ther. 373, 290&#x2013;301 10.1124/jpet.119.262790</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.119.262790</ArticleId><ArticleId IdType="pubmed">32060048</ArticleId></ArticleIdList></Reference><Reference><Citation>Abramyan A. M., Yano H., Xu M., Liu L., Naing S., Fant A. D., and Shi L. (2020) The Glu102 mutation disrupts higher-order oligomerization of the &#x3c3; 1 receptor. Comput. Struct. Biotechnol. J. 18, 199&#x2013;206 10.1016/j.csbj.2019.12.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2019.12.012</ArticleId><ArticleId IdType="pmc">PMC7005341</ArticleId><ArticleId IdType="pubmed">32055286</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavlyutov T. A., Epstein M. L., Andersen K. A., Ziskind-Conhaim L., and Ruoho A. E. (2010) The &#x3c3;1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral study. Neuroscience 167, 247&#x2013;255 10.1016/j.neuroscience.2010.02.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2010.02.022</ArticleId><ArticleId IdType="pmc">PMC2862368</ArticleId><ArticleId IdType="pubmed">20167253</ArticleId></ArticleIdList></Reference><Reference><Citation>Prause J., Goswami A., Katona I., Roos A., Schnizler M., Bushuven E., Dreier A., Buchkremer S., Johann S., Beyer C., Deschauer M., Troost D., and Weis J. (2013) Altered localization, abnormal modification and loss of function of &#x3c3; receptor-1 in amyotrophic lateral sclerosis. Hum. Mol. Genet. 22, 1581&#x2013;1600 10.1093/hmg/ddt008</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt008</ArticleId><ArticleId IdType="pubmed">23314020</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D. R., Siddique T., Patterson D., Figlewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H. X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362, 59&#x2013;62 10.1038/362059a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A., Andersen P. M., Chioza B., Shaw C., Sham P. C., Robberecht W., Matthijs G., Camu W., Marklund S. L., Forsgren L., Rouleau G., Laing N. G., Hurse P. V., Siddique T., Leigh P. N., et al. (1998) Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum. Mol. Genet. 7, 2045&#x2013;2050 10.1093/hmg/7.13.2045</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/7.13.2045</ArticleId><ArticleId IdType="pubmed">9817920</ArticleId></ArticleIdList></Reference><Reference><Citation>Puls I., Jonnakuty C., LaMonte B. H., Holzbaur E. L. F., Tokito M., Mann E., Floeter M. K., Bidus K., Drayna D., Oh S. J., Brown R. H., Ludlow C. L., and Fischbeck K. H. (2003) Mutant dynactin in motor neuron disease. Nat. Genet. 33, 455&#x2013;456 10.1038/ng1123</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1123</ArticleId><ArticleId IdType="pubmed">12627231</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y. Z., Bennett C. L., Huynh H. M., Blair I. P., Puls I., Irobi J., Dierick I., Abel A., Kennerson M. L., Rabin B. A., Nicholson G. A., Auer-Grumbach M., Wagner K., De Jonghe P., Griffin J. W., et al. (2004) DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet. 74, 1128&#x2013;1135 10.1086/421054</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/421054</ArticleId><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura A. L., Mitne-Neto M., Silva H. C. A., Richieri-Costa A., Middleton S., Cascio D., Kok F., Oliveira J. R. M., Gillingwater T., Webb J., Skehel P., and Zatz M. (2004) A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Hum. Genet. 75, 822&#x2013;831 10.1086/425287</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/425287</ArticleId><ArticleId IdType="pmc">PMC1182111</ArticleId><ArticleId IdType="pubmed">15372378</ArticleId></ArticleIdList></Reference><Reference><Citation>Sreedharan J., Blair I. P., Tripathi V. B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J. C., Williams K. L., Buratti E., Baralle F., De Belleroche J., Mitchell J. D., Leigh P. N., Al-Chalabi A., et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319, 1668&#x2013;1672 10.1126/science.1154584</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1154584</ArticleId><ArticleId IdType="pmc">PMC7116650</ArticleId><ArticleId IdType="pubmed">18309045</ArticleId></ArticleIdList></Reference><Reference><Citation>Chow C. Y., Landers J. E., Bergren S. K., Sapp P. C., Grant A. E., Jones J. M., Everett L., Lenk G. M., McKenna-Yasek D. M., Weisman L. S., Figlewicz D., Brown R. H., and Meisler M. H. (2009) Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS. Am. J. Hum. Genet. 84, 85&#x2013;88 10.1016/j.ajhg.2008.12.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2008.12.010</ArticleId><ArticleId IdType="pmc">PMC2668033</ArticleId><ArticleId IdType="pubmed">19118816</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura K. I., Matsumoto J., Niwa M., Kobayashi T., Kawashima Y., In Y., and Ishida T. (1997) Synthesis, structure and quantitative structure-activity relationships of &#x3c3; receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl) piperazines. Bioorg. Med. Chem. 5, 1675&#x2013;1683 10.1016/S0968-0896(97)00093-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0968-0896(97)00093-X</ArticleId><ArticleId IdType="pubmed">9313869</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagashira H., Zhang C., Lu Y.-M. M., Hasegawa H., Kanai H., Han F., and Fukunaga K. (2013) Stimulation of &#x3c3;1-receptor restores abnormal mitochondrial Ca2+ mobilization and ATP production following cardiac hypertrophy. Biochim. Biophys. Acta 1830, 3082&#x2013;3094 10.1016/j.bbagen.2012.12.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2012.12.029</ArticleId><ArticleId IdType="pubmed">23298811</ArticleId></ArticleIdList></Reference><Reference><Citation>Nango H., Kosuge Y., Miyagishi H., Sugawa K., Ito Y., and Ishige K. (2017) Prostaglandin E2 facilitates neurite outgrowth in a motor neuron-like cell line, NSC-34. J. Pharmacol. Sci. 135, 64&#x2013;71 10.1016/j.jphs.2017.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jphs.2017.09.001</ArticleId><ArticleId IdType="pubmed">28966102</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioda N., Imai Y., Yabuki Y., Sugimoto W., Yamaguchi K., Wang Y., Hikida T., Sasaoka T., Mieda M., and Fukunaga K. (2019) Dopamine D 2L receptor deficiency causes stress vulnerability through 5-HT 1A receptor dysfunction in serotonergic neurons. J. Neurosci. 39, 7551&#x2013;7563 10.1523/JNEUROSCI.0079-19.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0079-19.2019</ArticleId><ArticleId IdType="pmc">PMC6750932</ArticleId><ArticleId IdType="pubmed">31371425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z., Huang Z., and Lung M. (2013) Subcellular fractionation of cultured human cell lines. Bio-protocol. 3, e754 10.21769/BioProtoc.754</Citation><ArticleIdList><ArticleId IdType="doi">10.21769/BioProtoc.754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi T., Lewis A., Hayashi E., Betenbaugh M. J., and Su T. P. (2011) Antigen retrieval to improve the immunocytochemistry detection of sigma-1 receptors and ER chaperones. Histochem. Cell Biol. 135, 627&#x2013;637 10.1007/s00418-011-0811-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-011-0811-5</ArticleId><ArticleId IdType="pmc">PMC3155709</ArticleId><ArticleId IdType="pubmed">21573736</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider C. A., Rasband W. S., and Eliceiri K. W. (2012) NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671&#x2013;675 10.1038/nmeth.2089</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2089</ArticleId><ArticleId IdType="pmc">PMC5554542</ArticleId><ArticleId IdType="pubmed">22930834</ArticleId></ArticleIdList></Reference><Reference><Citation>Shioda N., Ishikawa K., Tagashira H., Ishizuka T., Yawo H., and Fukunaga K. (2012) Expression of a truncated form of the endoplasmic reticulum chaperone protein, &#x3c3;1 receptor, promotes mitochondrial energy depletion and apoptosis. J. Biol. Chem. 287, 23318&#x2013;23331 10.1074/jbc.M112.349142</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.349142</ArticleId><ArticleId IdType="pmc">PMC3390610</ArticleId><ArticleId IdType="pubmed">22619170</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh N. P. (2000) A simple method for accurate estimation of apoptotic cells. Exp. Cell Res. 256, 328&#x2013;337 10.1006/excr.2000.4810</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/excr.2000.4810</ArticleId><ArticleId IdType="pubmed">10739681</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>